Wright Don - 11 Jun 2024 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Director
Signature
/s/ Russell Kern, as Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
11 Jun 2024
Net transactions value
$0
Form type
4
Filing time
13 Jun 2024, 16:05:50 UTC
Previous filing
16 Jun 2023
Next filing
20 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO.OB Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 11 Jun 2024 Common Stock 30,000 $0.1200 Direct F1
transaction ISCO.OB Stock Option (Right to Buy) Award $0 +361,111 $0.000000 361,111 11 Jun 2024 Common Stock 361,111 $0.1200 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options shall vest on the earlier of (i) June 11, 2025 or (ii) the date of the 2025 Annual Meeting of Stockholders.
F2 Options shall vest in four equal quarterly increments, beginning September 11, 2024.